advertisement
Abstract #86184 Published in IGR 21-2
Steroid-induced glaucoma: Epidemiology, pathophysiology, and clinical management
Roberti G; Oddone F; Agnifili L; Katsanos A; Michelessi M; Mastropasqua L; Quaranta L; Riva I; Tanga L; Manni GSurvey of Ophthalmology 2020; 65: 458-472
Glucocorticoids are a class of anti-inflammatory drugs commonly used to treat various ocular and systemic conditions. Although the role of glucocorticoids in the treatment of numerous serious inflammatory diseases is pivotal, their prolonged use may increase intraocular pressure resulting in steroid-induced glaucoma. We provide a detailed update on steroid-induced glaucoma as a preventable cause of blindness in the adult and pediatric population and describe its epidemiology, social impact, and risk factors. Furthermore, we explore the propensity of different steroids to increase the intraocular pressure, the role of different routes of steroid administration, dosage and duration of treatment, as well as the clinical features, genetics, and management of steroid-induced glaucoma.
IRCCS - Fondazione Bietti, Rome, Italy.
Full articleClassification:
9.4.1 Steroid-induced glaucoma (Part of: 9 Clinical forms of glaucomas > 9.4 Glaucomas associated with other ocular and systemic disorders)
